ARMI is excited to present at the ISPE show on February 28th, showcasing innovative strategies to tackle historical industry challenges. Our approach focuses on adapting processes to scalable equipment, integrating automation, closing processes to mitigate risks, and establishing rigorous quality control specifications. We introduce the SMAC Manufacturing concept as the foundation for our Tissue Foundry prototype, emphasizing its potential to revolutionize manufacturing efficiency. Join us to learn about our interdisciplinary collaboration efforts and the critical role of quality control specifications in ensuring product efficacy through advanced data analytics.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
